US2001016624A1PendingUtilityA1
Degradable heterobifunctional poly (ethylene glycol) acrylates and gels and conjugates derived therefrom
Est. expiryJan 7, 2018(expired)· nominal 20-yr term from priority
A61K 47/60C08L 2203/02C08G 65/3322Y10S530/81Y10S530/816C08G 65/329C08L 71/02
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A heterobifunctional poly(ethylene glycol) is provided having a hydrolytically degradable linkage, a first terminus comprising an acrylate group, and a second terminus comprising a target such as a protein or pharmaceutical agent or a reactive moiety capable of coupling to a target. Hydrogels can be prepared. The hydrogels can be used as a carrier for a protein or a pharmaceutical agent that can be readily released in a controlled fashion.
Claims
exact text as granted — not AI-modifiedThat which is claimed is:
1 . A heterobifunctional polymer comprising:
a poly(alkylene oxide) backbone; a first terminus comprising an acrylate group; a second terminus comprising a target or a reactive moiety capable of coupling to a target; and a hydrolytically degradable linkage for releasing said target upon hydrolysis.
2 . A compound represented by the formula:
CH 2 ═CZ—CO 2 —POLY—W—POLY′—Q
where
Z represents H or alkyl;
POLY and POLY′ are poly(alkylene oxide) groups that can be the same or different and are represented by the formula
—(CH 2 CHRO) n —CH 2 CHR—
in which R is H or alkyl, and n ranges from about 10 to about 4000;
Q represents a functional group; and
W represents a hydrolytically unstable linkage.
3 . A compound represented by the formula:
CH 2 ═CZ—CO 2 —POLY—W—Q
where
Z represents H or alkyl;
POLY is poly(alkylene oxide), represented by the formula
—(CH 2 CHRO) n —CH 2 CHR—
in which R is H or alkyl, and n ranges from about 10 to about 4000;
Q represents a functional group; and
W represents a hydrolytically unstable linkage.
4 . The compound of either of claim 2 or 3 , wherein POLY and POLY′ are poly(ethylene glycol).
5 . The compound of either of claim 2 or 3 , wherein W comprises a hydrolyzable covalent bond selected from the group consisting of esters, orthoesters, imines, acetals, peptide bonds, and disulfides.
6 . The compound of either of claim 2 or 3 , wherein W has a structure of:
—O(CH 2 ) m —CO 2 R 1 —CO 2 —
where m ranges from 1 to 10, and R 1 is —CH 2 —, —CH 2 CH 2 — or —CH(CH 3 )CH 2 —, or W has the structure —O—(CH 2 ) m —CO 2 —.
7 . The compound of either of claim 2 or 3 , wherein Q is selected from the group consisting of aldehydes, carboxylic acids, active esters, active carbonates, sulfonate esters, amines, hydrazides, orthopyridyl disulfides, and thiols.
8 . A conjugate having a formula of:
(CH 2 ═CZ—CO 2 —POLY—W—POLY′—L) x —T
where
Z is H or an alkyl group;
POLY and POLY′ are poly(alkylene oxides) comprising groups that can be the same or different and are represented by the formula
—(CH 2 CHRO) n —CH 2 CHR—
in which R is H or alkyl, and n ranges from about 10 to about 4000;
W represents a hydrolytically unstable linkage;
L is hydrolytically stable linkage;
x is an integer of 1-10; and
T is a target molecule.
9 . The conjugate of claim 7 , wherein R is H.
10 . The conjugate of claim 7 , wherein W has the structure of:
—O(CH 2 ) m —CO 2 R 1 —CO 2 —
where m ranges from 1 to 10, R 1 is selected from the group consisting of —CH 2 —, —CH 2 CH 2 —, and —CH(CH 3 )CH 2 — or W has the structure —O—(CH 2 ) m —CO 2 —.
11 . The conjugate of claim 7 , wherein T is selected from the group consisting of proteins, polysaccharides, oligonucleotides, lipids, vitamins, hormones, or small molecule pharmaceuticals.
12 . A compound having the following structure:
CH 2 ═CZCO 2 —POLY—W—Q
where
Z represents H or alkyl;
POLY is a poly(alkylene oxide) represented by the formula
—(CH 2 CHRO) n —CH 2 CHR—
in which R is H or alkyl, and n ranges from about 10 to about 4000;
Q represents a functional group; and
W represents a hydrolytically unstable linkage.
13 . The compound of claim 11 , wherein POLY is poly(ethylene glycol).
14 . The compound of claim 11 , wherein W comprises a hydrolyzable covalent bond selected from the group consisting of esters, orthoesters, imines, acetals, peptide bonds, and disulfides.
15 . The compound of claim 11 , wherein W has the structure of:
—O(CH 2 ) m —CO 2 R 1 —CO 2 —
where m ranges from 1 to 10 and R 1 is —CH 2 —, —CH 2 CH 2 —, or —CH(CH 3 )CH 2 — or W has the structure —O—(CH 2 ) m —CO 2 —.
16 . The compound of claim 11 , wherein Q is selected from the group consisting of aldehydes, carboxylic acids, active esters, active carbonates, sulfonate esters, amines, hydrazides, orthopyridyl disulfides, N-succinimidyl, and thiols.
17 . A conjugate having the following structure:
(CH 2 ═CZCO 2 —POLY—W—L) x —T
where
Z represents H or alkyl;
POLY is a poly(alkylene oxide) comprising a group represented by the formula
—(CH 2 CHRO) n —CH 2 CHR—
in which R is H or alkyl, and n ranges from about 10 to about 4000;
W represents a hydrolytically unstable linkage;
L is a hydrolytically stable linkage;
x is an integer from 1 to 10; and
T is a target molecule.
18 . A polymer selected from the group consisting of compounds represented by the formula:
CH 2 ═CZ—CO 2 —POLY—W—POLY′—Q 1 , (CH 2 ═CZ—CO 2 —POLY—W—POLY′—L) x —T, CH 2 ═CZCO 2 —POLY—W—Q, and (CH 2 ═CZCO 2 —POLY—W—L) x —T,
where
Z is H or an alkyl group;
POLY and POLY′ are poly(alkylene oxides) that can be the same or different and are represented by the formula
—(CH 2 CHRO) n —CH 2 CHR—
in which R is H or alkyl, and n ranges from about 10 to about 4000;
W represents a hydrolytically unstable linkage;
Q represents a functional group;
L is hydrolytically stable linkage;
x is an integer of 1-10; and
T is a target molecule.
19 . The polymer composition of claim 17 , wherein W has the structure of:
—O(CH 2 ) m —CO 2 R 1 —CO 2 —
where m ranges from 1 to 10, R 1 is selected from the group consisting of —CH 2 —, —CH 2 CH 2 —, and —CH(CH 3 )CH 2 — or W has the structure of —O—(CH 2 ) m —CO 2 —.
20 . The polymer composition of claim 17 , wherein T is a protein.
21 . The polymer composition of claim 17 , wherein R is H.
22 . A hydrogel comprising a co-polymerization product of a multiacrylate and at least one compound selected from the group consisting of compounds represented by the formula:
CH 2 ═CZ—CO 2 —POLY—W—POLY′—Q 1 , (CH 2 ═CZ—CO 2 —POLY—W−POLY′—L) x —T, CH 2 ═CZCO 2 —POLY—W—Q, and (CH 2 ═CZCO 2 —POLY—W—L) x T,
where
Z is H or an alkyl group;
POLY and POLY′ are poly(alkylene oxides) that may be the same or different and are represented by the formula
—(CH 2 CHRO) n —CH 2 CHR—
in which R is H or alkyl, and n ranges from about 10 to about 4000;
W represents a hydrolytically unstable linkage;
Q represents a functional group;
L is hydrolytically stable linkage;
x is an integer of 1-10; and
T is a target molecule.
23 . The hydrogel of claim 21 , wherein said multiacrylate is selected from the group consisting of PEG diacrylates and N-vinylpyrrolidone.
24 . The hydrogel of claim 22 , wherein said PEG diacrylate is CH 2 ═CHCO 2 —PEG—O—CH 2 CO 2 CH(CH 3 )CH 2 CONH—PEGO 2 CCH═CH 2 or CH 2 ═CHCO 2 —PEG—O—CH 2 CO 2 PEG—O 2 CCH═CH 2+L.
25 . The hydrogel of claim 21 , wherein T is a protein.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.